Pneumologie

Issue S 01 · March 2019

eFirst
Issue
60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.
München, 13.–16.03.2019

Kongresspräsident: Prof. Dr. med. Jürgen Behr, München

Abstracts (HTML) List of Authors
- Posterbegehung (P05) – Sektion Klinische Pneumologie
- Asthma 2019
P296
Schulze, J; Smith, HJ; Eichhorn, C; Salzmann-Manrique, E; Dreßler, M; Zielen, S:
Zusammenhang von Spirometrie und Bodyplethysmographie während einer Belastung induzierten bronchialen Obstruktion
FREE ACCESS
- Abstract
P327
Beck, E; Kaplan, A; Fitzgerald, JM; Azzi, GE; Engel, M; Buhl, R:
Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review
FREE ACCESS
- Abstract
P400
Schultz, K; Wittmann, M; Wagner, R; Lehbert, N; Szentes, B; Schwarzkopf, L; Nowak, D; Faller, H; Schuler, M:
Absolute Eosinophilenzahl und klinischer Verlauf von 333 konsekutiven Rehabilitanden mit nicht kontrolliertem Asthma
FREE ACCESS
- Abstract
P492
Munro, A; Vos, W; Mignot, B; Müllinger, B:
Evaluierung von Lungendepositionsmustern für ICS mit verschiedenen Inhalationsgeräten in Patienten mit schwerem Asthma mittels eines In-Silico-Depositions-Modells
FREE ACCESS
- Abstract
P524
Mailänder, C:
Omalizumab Selbstapplikation – Umfrage bei Ärzten und Patienten
FREE ACCESS
- Abstract
P601
Svedsater, H; Bosanquet, N; Jacques, L; Jones, R; LayFlurrie, J; Leather, DA; Vestbo, J; Woodcock, A:
Effects of Fluticasone furoate/Vilanterol (FF/VI) on Patient Reported Outcomes (PRO): The Salford Lung Study in Asthma (SLS Asthma)
FREE ACCESS
- Abstract
P664
OʼByrne, P; Fitzgerald, JM; Bateman, E; Barnes, PJ; Zhong, N; Gustafson, P; Lamarca, R; Puu, M; Keen, C; Wang, M; Reddel, HK:
Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma
FREE ACCESS
- Abstract
P714
Marth, K; Renner, A; Patocka, K; Pohl, W:
Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria
FREE ACCESS
- Abstract
P254
Zangrilli, JG; Maspero, J; Harrison, T; Werkstrom, V; Wu, Y:
Clinical Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma and Nasal Polyposis: Pooled Analysis of the SIROCCO and CALIMA Trials
FREE ACCESS
- Abstract
P261
Buhl, R; Heaney, L; Loefroth, E; Larbig, M; Konstantinos, K; Corti, V; Cao, H:
Disease control and treatment pathways of asthma patients after initiating ICS/LABA
FREE ACCESS
- Abstract
P262
Beck, E; Fitzgerald, JM; Buhl, R; Casale, TB; Azzi, GE; Engel, M; Sigmund, R; Halpin, DMG:
Tiotropium Respimat reduces episodes of asthma worsening in PrimoTinA-asthma, irrespective of baseline characteristics or season
FREE ACCESS
- Abstract
P464
Müllinger, B; Kolb, T; Gessler, T:
Inhalationsgeräte mit kontrollierter Inhalation verbessern patientenrelevante Behandlungsergebnisse
FREE ACCESS
- Abstract
P530
Wiener, S; Wegner, S; Ernst, C:
Cost Analysis of FeNO-based Asthma Management in Primary Care in Germany
FREE ACCESS
- Abstract
P558
Adamek, L; Plate, T; Shavit, A; Kanniess, F; Beier, J:
DescRiption and charactErisation of asthmatiCs eligible for biolOGic therapy referral amoNg prImary and secondary care SEttings in Europe (RECOGNISE) study design, German part
FREE ACCESS
- Abstract
P236
Zangrilli, JG; Kamboj, A; Newbold, P; Hirsch, I:
Characteristics of Patients With and Without Allergic Disease From Benralizumab Phase III Severe Asthma Trials
FREE ACCESS
- Abstract